Cargando…
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733007/ https://www.ncbi.nlm.nih.gov/pubmed/34987163 http://dx.doi.org/10.1038/s41408-021-00600-6 |
| _version_ | 1784627725292535808 |
|---|---|
| author | Claveau, Jean-Sébastien Savary Bélanger, Sophie Ahmad, Imran Delisle, Jean-Sébastien De Guire, Vincent Roy, Jean LeBlanc, Richard |
| author_facet | Claveau, Jean-Sébastien Savary Bélanger, Sophie Ahmad, Imran Delisle, Jean-Sébastien De Guire, Vincent Roy, Jean LeBlanc, Richard |
| author_sort | Claveau, Jean-Sébastien |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8733007 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87330072022-01-18 Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma Claveau, Jean-Sébastien Savary Bélanger, Sophie Ahmad, Imran Delisle, Jean-Sébastien De Guire, Vincent Roy, Jean LeBlanc, Richard Blood Cancer J Correspondence Nature Publishing Group UK 2022-01-05 /pmc/articles/PMC8733007/ /pubmed/34987163 http://dx.doi.org/10.1038/s41408-021-00600-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Claveau, Jean-Sébastien Savary Bélanger, Sophie Ahmad, Imran Delisle, Jean-Sébastien De Guire, Vincent Roy, Jean LeBlanc, Richard Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| title | Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| title_full | Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| title_fullStr | Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| title_full_unstemmed | Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| title_short | Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| title_sort | early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733007/ https://www.ncbi.nlm.nih.gov/pubmed/34987163 http://dx.doi.org/10.1038/s41408-021-00600-6 |
| work_keys_str_mv | AT claveaujeansebastien earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma AT savarybelangersophie earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma AT ahmadimran earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma AT delislejeansebastien earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma AT deguirevincent earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma AT royjean earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma AT leblancrichard earlyfreelightchainreductionfollowingtreatmentinitiationpredictsfavorableoutcomeinintactimmunoglobulinmyeloma |